Literature DB >> 26210386

Dramatic decrease of Streptococcus pneumoniae infections in Marseille, 2003-2014.

C Abat1, D Raoult1, J-M Rolain2.   

Abstract

We studied the evolution of the prevalence of pneumococcal infections in university hospitals in Marseille, France, from January 2003 to December 2014, and compared our observations and results to available international data. We collected data referring to patients hospitalised for Streptococcus pneumoniae infections in the four university hospitals of Marseille from January 2003 to December 2014. We then calculated percentages of positiveness to pneumococcal strains by dividing the annual number of patients infected by pneumococcal strains by the annual number of patients found to be infected by at least one bacterial species in the settings of interest throughout the study period. Overall, 2442 non-redundant patients were infected by S. pneumoniae strains throughout the study period. We observed that the annual percentage of patients infected by S. pneumoniae significantly decreased throughout the study period (from 1.99% in 2003 to 0.77% in 2014, p-value < 10(-4)). A significant correlation was obtained comparing the annual evolution of the percentage of patients positive to pneumococcal strains aged under 21 years to that of patients aged over 21 years (r = 0.93, p-value < 10(-5)). Our results allowed us to prove that national immunisation programmes effectively impact on the pneumococcal infection prevalence in young and elderly populations, even on the regional scale.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26210386     DOI: 10.1007/s10096-015-2455-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  Holiday spikes in pneumococcal disease among older adults.

Authors:  Nicholas D Walter; Thomas H Taylor; Scott F Dowell; Saundra Mathis; Matthew R Moore
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

3.  Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.

Authors:  M Kempf; E Varon; A Lepoutre; A Gravet; R Baraduc; M Brun; H Chardon; J Cremniter; J Croizé; F Dalmay; M-C Demachy; T Fosse; C Grelaud; T Hadou; F Hamdad; J-L Koeck; S Luce; S Mermond; I Patry; A Péchinot; J Raymond; A Ros; C Segonds; B Soullié; D Tandé; M Vergnaud; V Vernet-Garnier; F Wallet; L Gutmann; M-C Ploy; P Lanotte
Journal:  Clin Microbiol Infect       Date:  2014-10-12       Impact factor: 8.067

4.  Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.

Authors:  Natalie G Martin; Manish Sadarangani; Andrew J Pollard; Michael J Goldacre
Journal:  Lancet Infect Dis       Date:  2014-03-14       Impact factor: 25.071

5.  Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.

Authors:  Karen E Lamb; Stefan Flasche; Mathew Diggle; Donald Inverarity; David Greenhalgh; Johanna M Jefferies; Andrew Smith; Giles F S Edwards; Barbara Denham; Jim McMenamin; Eisin McDonald; Tim J Mitchell; Stuart C Clarke; Chris Robertson
Journal:  Vaccine       Date:  2013-06-24       Impact factor: 3.641

6.  Herd protection induced by pneumococcal conjugate vaccine.

Authors:  Keith P Klugman
Journal:  Lancet Glob Health       Date:  2014-05-28       Impact factor: 26.763

7.  Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

Authors:  A Lepoutre; E Varon; S Georges; F Dorléans; C Janoir; L Gutmann; D Lévy-Bruhl
Journal:  Vaccine       Date:  2014-11-20       Impact factor: 3.641

8.  Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study.

Authors:  Rodrigo Lopez Castelblanco; MinJae Lee; Rodrigo Hasbun
Journal:  Lancet Infect Dis       Date:  2014-08-04       Impact factor: 25.071

9.  Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012.

Authors:  S I Aguiar; M J Brito; A N Horacio; J P Lopes; M Ramirez; J Melo-Cristino
Journal:  Euro Surveill       Date:  2014-03-27

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  3 in total

1.  Penicillin-Binding Protein Typing, Antibiotic Resistance Gene Identification, and Molecular Phylogenetic Analysis of Meropenem-Resistant Streptococcus pneumoniae Serotype 19A-CC3111 Strains in Japan.

Authors:  Satoshi Nakano; Takao Fujisawa; Yutaka Ito; Bin Chang; Yasufumi Matsumura; Masaki Yamamoto; Shigeru Suga; Makoto Ohnishi; Miki Nagao
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.

Authors:  Adamos Hadjipanayis; Elisavet Efstathiou; Maria Alexandrou; Loukia Panayiotou; Chrystalla Zachariadou; Panayiotis Petrou; Vasiliki Papaevangelou
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

3.  Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.

Authors:  Satoshi Nakano; Takao Fujisawa; Yutaka Ito; Bin Chang; Yasufumi Matsumura; Masaki Yamamoto; Shigeru Suga; Makoto Ohnishi; Miki Nagao
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.